A six-month text messaging program improved blood sugar levels in low-income Hispanics with Type 2 diabetes, rivaling some glucose-lowering medications. The study found that participants who engaged more with the messages had better A1C measures.
Researchers found genetic mutations increased with donor age, particularly in late 80s and early 90s donors, which could impact iPSC therapies. Screening is crucial to filter out defects and ensure safe treatment.
Researchers from Scripps Translational Science Institute discovered a higher-than-normal presence of genetic variants offering protection from cognitive decline in the 'Wellderly' study. These variants were found to be associated with long-term cognitive health and protection from chronic diseases, including cancer and heart disease.
Scripps Health cardiology experts will share leading-edge techniques for improving heart care during the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium. Matthew Price, M.D., will present on the WATCHMAN left atrial appendage closure device, an alternative to blood thinners for stroke prevention.
Studies by Scripps Whittier Diabetes Institute found that poorly controlled blood sugar levels result in significantly longer and more expensive hospital stays. Care teams focused on managing diabetes during hospitalization can improve patient outcomes and reduce costs.
A nationwide survey shows a significant growth in pediatric proton therapy patients, with 56% under age 10. Proton therapy offers precise treatment for various tumor diagnoses, including ependymoma and medulloblastoma.
The Scripps Proton Therapy Center in San Diego is reporting exceptional results in delivering cancer treatment using pencil-beam scanning technology, enabling the treatment of a wide range of tumor sites. The center has treated patients with lung, brain, spinal column, and other tumors, offering greater precision and efficiency in radi...
Leading cardiac specialists have proposed new guidelines for donor heart allocation to increase patient survival rates. The revised system considers factors such as illness severity, waiting list mortality, and geographic variations in allocations.
Researchers at Scripps Translational Science Institute are using DNA to investigate sudden deaths in San Diego County, aiming to identify genetic mechanisms and develop preventative screening programs. The study hopes to provide closure for families and potentially save lives.
Researchers at Scripps Translational Science Institute have identified a new genetic cause of epileptic encephalopathy, a severe and complex form of epilepsy. The KCNB1 gene mutation was found in a 10-year-old girl, offering new treatment options for her condition.
A Scripps Whittier study shows that text messages can help improve glycemic control in Latino patients with type 2 diabetes. The intervention used text messages to provide healthy nutrition tips, physical activity reminders, and medication adherence encouragement.
A multicenter study found a mobile compression device to be as effective as blood thinners in preventing deep vein thrombosis (DVT) after lower extremity joint replacement surgery. The device improved blood flow and had no negative side effects, making it an equally safe alternative to blood thinners.
A Scripps Health study suggests that a ZIO Patch, worn on the chest for up to two weeks, detects abnormal heart rhythms more effectively than a traditional Holter monitor. The patch's extended monitoring period led to significantly more arrhythmia events being detected.
Researchers at Scripps Translational Science Institute used wireless health sensors to collect data from meditators, studying the immediate effects of meditation on blood pressure and markers of stress. The study aims to guide better treatments for high blood pressure and other health conditions.
Genetic sequencing technology is altering cancer diagnosis and treatment, but traditional specimen handling methods slow progress. Scripps physicians propose freezing tumor tissue to preserve DNA coding, potentially leading to better diagnoses and treatments.
The funding will support clinical trials of wireless biosensor systems and rapid pharmacogenomic diagnostic tests to track heart attacks and Type 1 diabetes. Scripps Digital Medicine aims to revolutionize healthcare with breakthrough technologies, including DNA sequencing tools.
A randomized controlled trial found that combining healing touch and guided imagery significantly improved PTSD symptoms in returning active-duty Marines. The study reported substantial clinical reductions in depression and cynicism, with scores decreasing by 14 points below the clinical cutoffs for PTSD diagnosis.
A novel ambulatory cardiac monitor, Zio Patch, has been found to be effective in diagnosing irregular heart rhythms and preventing unnecessary follow-up care. The study showed that 59% of symptomatic patients did not have arrhythmia and may not require further work-up.
A new study published in Science Translational Medicine shows a promising blood test that can predict who is at risk for an imminent heart attack, potentially saving thousands of lives. The test uses circulating endothelial cells, which are abnormally large and misshapen in patients with acute myocardial infarction.
Researchers found that obese patients taking sleeping pills have a significantly higher risk of mortality, nearly doubling the rate even among those prescribed fewer than 18 pills per year. The study also revealed a stronger association in men and young adults, with obesity emerging as a marker of increased vulnerability.
A Scripps Clinic study found that sleeping pill users are at a 4.6 times higher risk of death, with rates of new cancers being 35% higher among regular users. The research suggests alternatives to hypnotic medications and emphasizes the importance of treating underlying psychological disorders.
A Scripps-led study published in JAMA finds that the new drug cangrelor successfully 'bridges' patients with recent stents to cardiac surgery without excessive bleeding. The trial showed 99% of cangrelor-treated patients maintained target levels of platelet inhibition.
A new Scripps Health study aims to fill the knowledge gap on idiopathic human diseases by using whole genome sequencing to determine their causes. The study, dubbed IDIOM, will include up to six participants and collaborate with other medical centers to share key findings.